HADALMA Trademark

Trademark Overview

On Monday, January 11, 2016, a trademark application was filed for HADALMA with the United States Patent and Trademark Office. The USPTO has given the HADALMA trademark a serial number of 86871123. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2019. This trademark is owned by Merck Sharp & Dohme Corp.. The HADALMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of rheumatoid arthritis, Crohn's disease and psoriasis
hadalma

General Information

Serial Number86871123
Word MarkHADALMA
Filing DateMonday, January 11, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of rheumatoid arthritis, Crohn's disease and psoriasis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 16, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, August 5, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 5, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 14, 2018EXTENSION 5 GRANTED
Wednesday, December 5, 2018EXTENSION 5 FILED
Thursday, December 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 5, 2018TEAS EXTENSION RECEIVED
Saturday, June 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 14, 2018EXTENSION 4 GRANTED
Thursday, June 14, 2018EXTENSION 4 FILED
Thursday, June 14, 2018TEAS EXTENSION RECEIVED
Wednesday, December 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2017EXTENSION 3 GRANTED
Monday, December 18, 2017EXTENSION 3 FILED
Monday, December 18, 2017TEAS EXTENSION RECEIVED
Friday, October 6, 2017ASSIGNED TO EXAMINER
Saturday, June 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 15, 2017EXTENSION 2 GRANTED
Thursday, June 15, 2017EXTENSION 2 FILED
Thursday, June 15, 2017TEAS EXTENSION RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 13, 2016EXTENSION 1 GRANTED
Tuesday, December 13, 2016EXTENSION 1 FILED
Tuesday, December 13, 2016TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 26, 2016ASSIGNED TO EXAMINER
Saturday, January 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 14, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

hadalma crohn disease psoriasis arthritis rheumatoid preparations treatment pharmaceutical